SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
Skye Bioscience, Inc.
@SKYE_InsiderForm 4 Filing: DHILLON PUNIT Acquires (Grant) shares of $SKYE
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Skye Bioscience, Inc.
Ticker: $SKYE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-07
Shares: 1,090,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, DHILLON PUNIT, holds the title of Chief Executive Officer at Skye Bioscience, Inc..
On 2026-08-07, the insider transacted 1,090,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
DHILLON PUNIT (Chief Executive Officer) was granted $0 of $SKYE
Post-Transaction Position: 1,419,823 shares
SEC Accession No: 0001628280-26-054941 (CIK: 1425052)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.